Bayer, Curadev ink pact to discover drug candidates for lung, cardiovascular, inflammatory diseases

Global pharma and life sciences major Bayer and domestic drug discovery firm Curadev have signed a research collaboration and licence agreement to discover new drug candidates for treatment of lung, cardiovascular and inflammatory diseases.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/33Dk01K
via IFTTT